Of note, NGAL protein has been suggested as a promising biomarker for IBD, since its fecal levels, if elevated, are significantly associated with disease activity and severity (Thorsvik et al., 2017; Yeşil et al., 2013; Zinkevich et al., 2014). This evidence concerns the gene LCN2 and inflammatory bowel disease.